Strides Pharma Science Limited
NSE:STAR.NS
1328 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 40,511.24 | 36,883.87 | 30,220.56 | 32,511.55 | 26,567.45 | 29,437.86 | 27,965.21 | 33,557.28 | 30,310.89 | 11,320.21 | 10,727.688 | 22,044.72 | 25,245.19 | 16,958.44 | 13,047.71 | 10,203.31 | 7,256.12 | 7,429.84 | 5,237.18 | 4,485.26 |
| Cost of Revenue
| 26,123.13 | 16,268.85 | 15,832.84 | 14,087.8 | 11,839.82 | 15,040.13 | 14,244.53 | 15,428.5 | 15,307.22 | 5,604.82 | 6,151.056 | 9,980.13 | 14,763.65 | 8,784.24 | 7,565.5 | 5,867.65 | 4,176.86 | 3,846.12 | 2,407.32 | 2,270.78 |
| Gross Profit
| 14,388.11 | 20,615.02 | 14,387.72 | 18,423.75 | 14,727.63 | 14,397.73 | 13,720.68 | 18,128.78 | 15,003.67 | 5,715.39 | 4,576.632 | 12,064.59 | 10,481.54 | 8,174.2 | 5,482.21 | 4,335.66 | 3,079.26 | 3,583.72 | 2,829.86 | 2,214.48 |
| Gross Profit Ratio
| 0.355 | 0.559 | 0.476 | 0.567 | 0.554 | 0.489 | 0.491 | 0.54 | 0.495 | 0.505 | 0.427 | 0.547 | 0.415 | 0.482 | 0.42 | 0.425 | 0.424 | 0.482 | 0.54 | 0.494 |
| Reseach & Development Expenses
| 595.44 | 638.65 | 893.88 | 1,059.1 | 1,039.65 | 1,285.83 | 1,189.93 | 1,575.08 | 1,906.46 | 393.9 | 1,129.12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 1,476.83 | 1,512.08 | 1,151.25 | 1,151 | 1,062.32 | 944.98 | 1,017.12 | 880.88 | 404.47 | 305.312 | 587.04 | 2,270.09 | 1,639.17 | 1,162.71 | 1,177.83 | 1,177.9 | 780.85 | 640.53 | 478.4 |
| Selling & Marketing Expenses
| 0 | 2,636.51 | 3,312.97 | 2,232.18 | 166.61 | 607.39 | 852.28 | 763.3 | 506.78 | 271.06 | 533.4 | 276.46 | 476.24 | 388.26 | 357.39 | 334.82 | 206.46 | 193.61 | 135.14 | 92.29 |
| SG&A
| 9,162.3 | 4,113.34 | 4,825.05 | 3,383.43 | 1,317.61 | 1,669.71 | 1,797.26 | 1,780.42 | 1,387.66 | 675.53 | 2,328.856 | 863.5 | 2,746.33 | 2,027.43 | 1,520.1 | 1,512.65 | 1,384.36 | 974.46 | 775.67 | 570.69 |
| Other Expenses
| 397.01 | 18,745.73 | 11,980.18 | 10,827.61 | 9,746.67 | 135.85 | 203.07 | 105.18 | 98.07 | 150.15 | 0 | 101.28 | 4,401.19 | 2,822.54 | 2,348.97 | -1,060.59 | 882.1 | 1,535.88 | 1,120.65 | 796.59 |
| Operating Expenses
| 9,162.3 | 18,745.73 | 16,805.23 | 14,211.04 | 11,064.28 | 11,454.26 | 11,295.55 | 13,304.49 | 11,311.34 | 3,924.09 | 3,458.152 | 7,122.56 | 7,147.52 | 4,849.97 | 3,869.07 | 452.06 | 2,266.46 | 2,510.34 | 1,896.32 | 1,367.28 |
| Operating Income
| 5,225.81 | -796.99 | -2,824.27 | 4,569.21 | 2,081.6 | 2,943.47 | 2,425.13 | 4,824.29 | 3,692.33 | 1,791.3 | 1,598.416 | 4,942.03 | 3,334.02 | 3,324.23 | 1,613.14 | 3,883.6 | 812.8 | 1,073.38 | 933.54 | 847.2 |
| Operating Income Ratio
| 0.129 | -0.022 | -0.093 | 0.141 | 0.078 | 0.1 | 0.087 | 0.144 | 0.122 | 0.158 | 0.149 | 0.224 | 0.132 | 0.196 | 0.124 | 0.381 | 0.112 | 0.144 | 0.178 | 0.189 |
| Total Other Income Expenses Net
| -4,637.89 | -2,065.01 | -3,700.86 | -1,814.82 | -1,534.8 | -2,222.92 | -1,625.66 | -1,853.36 | -1,116.75 | -305.52 | -864.424 | 4,552.87 | -607.16 | -1,460.51 | -183.77 | -2,734.81 | -1,158.49 | -408.03 | -341.27 | -306.3 |
| Income Before Tax
| 587.92 | -2,862 | -6,525.13 | 2,754.39 | 546.8 | 720.55 | 799.47 | 2,970.93 | 2,575.58 | 1,485.78 | 733.992 | 9,494.9 | 2,726.86 | 1,863.72 | 1,429.37 | 1,148.79 | -345.69 | 665.35 | 592.27 | 540.9 |
| Income Before Tax Ratio
| 0.015 | -0.078 | -0.216 | 0.085 | 0.021 | 0.024 | 0.029 | 0.089 | 0.085 | 0.131 | 0.068 | 0.431 | 0.108 | 0.11 | 0.11 | 0.113 | -0.048 | 0.09 | 0.113 | 0.121 |
| Income Tax Expense
| 315.9 | -553.01 | -1,782.63 | 316.51 | 113.23 | 131.22 | 97.33 | 470 | 688.55 | 532.3 | 2,596.296 | 1,021.45 | 386.8 | 451.94 | 218.99 | 107.94 | 170.85 | 173.53 | 34.25 | 123.85 |
| Net Income
| -1,248.34 | -2,308.99 | -4,742.5 | 2,684.42 | 363.91 | 3,246.18 | 6,604.69 | 3,997.49 | 2,089.36 | 8,449.99 | -1,867.056 | 8,462.37 | 2,244.75 | 1,224.47 | 1,096.83 | 1,079.63 | -501.21 | 402.29 | 485.64 | 439.98 |
| Net Income Ratio
| -0.031 | -0.063 | -0.157 | 0.083 | 0.014 | 0.11 | 0.236 | 0.119 | 0.069 | 0.746 | -0.174 | 0.384 | 0.089 | 0.072 | 0.084 | 0.106 | -0.069 | 0.054 | 0.093 | 0.098 |
| EPS
| -13.65 | -25.63 | -52.84 | 28.4 | 2.7 | 36.25 | 73.81 | 44.73 | 13.14 | 141.85 | -31.55 | 144.3 | 38.55 | 26.11 | 26.49 | 26.91 | -5.6 | 10.55 | 13.43 | 13.13 |
| EPS Diluted
| -13.62 | -25.63 | -52.84 | 28.37 | 2.7 | 36.24 | 73.79 | 44.64 | 13.06 | 141.27 | -31.55 | 131.85 | 38.32 | 24.56 | 19.67 | 24.7 | -5.6 | 9.33 | 12.17 | 13.13 |
| EBITDA
| 7,432.64 | 1,635.53 | -494.13 | 6,632.08 | 3,959.51 | 3,580.31 | 4,489.57 | 8,115.43 | 5,696.39 | 2,389.64 | 2,050.264 | 5,285.41 | 5,292.44 | 3,957.22 | 1,530.71 | 6,175.8 | 1,751.67 | 1,409.56 | 1,179.81 | 1,061.38 |
| EBITDA Ratio
| 0.183 | 0.044 | -0.016 | 0.204 | 0.149 | 0.122 | 0.161 | 0.242 | 0.188 | 0.211 | 0.191 | 0.24 | 0.21 | 0.233 | 0.117 | 0.605 | 0.241 | 0.19 | 0.225 | 0.237 |